お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、経皮パッチの世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に経皮パッチ市場を分類しています。
本レポートでは世界の経皮パッチ市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Hisamitsu Pharmaceutical、Johnson & Johnson、Novartis、UCB Pharma、Mylan、Teva Pharmaceutical、Nitto Denko、Grünenthal、IBSA Group、GSK、Luye Pharma Group、Pfizer、Chattem、Dr Reddy’s Laboratories、Bayer、Mundipharma、Endo International、Beijing Tide Pharmaceutical

レポートは経皮パッチの主要生産者を調査し、主要地域や国の消費状況も提供します。経皮パッチの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Methyl Salicylate-based Patch
    Rivastigmine Transdermal Patch
    Fentanyl Transdermal Patch
    Lidocaine Patch
    Diclofenac Patch
    Nicotine Transdermal Patch
    Others

用途別の市場セグメント：
    Rx Channel
    OTC Channel

本レポートの詳細内容
本レポートは、世界の経皮パッチ市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて経皮パッチ市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）の経皮パッチ生産量、成長率、市場シェアを調査している。

二. 消費面では、経皮パッチの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーの経皮パッチ売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の経皮パッチ市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本経皮パッチのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：経皮パッチのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： 経皮パッチの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおける経皮パッチの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章経皮パッチメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：経皮パッチの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：経皮パッチの主要メーカーの概要を提供し、製品の説明と仕様、経皮パッチの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：経皮パッチの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
The global Transdermal Patch market is projected to grow from US$ 7058.3 million in 2024 to US$ 8726.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.6% during the forecast period.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.
Report Covers:
This report presents an overview of global market for Transdermal Patch, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Transdermal Patch, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Transdermal Patch, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Transdermal Patch sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Transdermal Patch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Transdermal Patch sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
    Hisamitsu Pharmaceutical
    Johnson & Johnson
    Novartis
    UCB Pharma
    Mylan
    Teva Pharmaceutical
    Nitto Denko
    Grünenthal
    IBSA Group
    GSK
    Luye Pharma Group
    Pfizer
    Chattem
    Dr Reddy’s Laboratories
    Bayer
    Mundipharma
    Endo International
    Beijing Tide Pharmaceutical

Segment by Type
    Methyl Salicylate-based Patch
    Rivastigmine Transdermal Patch
    Fentanyl Transdermal Patch
    Lidocaine Patch
    Diclofenac Patch
    Nicotine Transdermal Patch
    Others

Segment by Application
    Rx Channel
    OTC Channel

Segment by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Transdermal Patch in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Transdermal Patch manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transdermal Patch sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
    Table 1. Global Transdermal Patch Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Methyl Salicylate-based Patch
    Table 3. Major Manufacturers of Rivastigmine Transdermal Patch
    Table 4. Major Manufacturers of Fentanyl Transdermal Patch
    Table 5. Major Manufacturers of Lidocaine Patch
    Table 6. Major Manufacturers of Diclofenac Patch
    Table 7. Major Manufacturers of Nicotine Transdermal Patch
    Table 8. Major Manufacturers of Others
    Table 9. Global Transdermal Patch Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 10. Global Transdermal Patch Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Transdermal Patch Revenue by Region (2019-2024) & (US$ Million)
    Table 12. Global Transdermal Patch Revenue by Region (2025-2030) & (US$ Million)
    Table 13. Global Transdermal Patch Revenue Market Share by Region (2019-2024)
    Table 14. Global Transdermal Patch Revenue Market Share by Region (2025-2030)
    Table 15. Global Transdermal Patch Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 16. Global Transdermal Patch Sales by Region (2019-2024) & (M Pcs)
    Table 17. Global Transdermal Patch Sales by Region (2025-2030) & (M Pcs)
    Table 18. Global Transdermal Patch Sales Market Share by Region (2019-2024)
    Table 19. Global Transdermal Patch Sales Market Share by Region (2025-2030)
    Table 20. Global Transdermal Patch Sales by Manufacturers (2019-2024) & (M Pcs)
    Table 21. Global Transdermal Patch Sales Share by Manufacturers (2019-2024)
    Table 22. Global Transdermal Patch Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 23. Global Transdermal Patch Revenue Share by Manufacturers (2019-2024)
    Table 24. Global Key Players of Transdermal Patch, Industry Ranking, 2022 VS 2023 VS 2024
    Table 25. Transdermal Patch Price by Manufacturers 2019-2024 (USD/Pc)
    Table 26. Global Transdermal Patch Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 27. Global Transdermal Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Patch as of 2023)
    Table 28. Global Key Manufacturers of Transdermal Patch, Manufacturing Base Distribution and Headquarters
    Table 29. Global Key Manufacturers of Transdermal Patch, Product Offered and Application
    Table 30. Global Key Manufacturers of Transdermal Patch, Date of Enter into This Industry
    Table 31. Mergers & Acquisitions, Expansion Plans
    Table 32. Global Transdermal Patch Sales by Type (2019-2024) & (M Pcs)
    Table 33. Global Transdermal Patch Sales by Type (2025-2030) & (M Pcs)
    Table 34. Global Transdermal Patch Sales Share by Type (2019-2024)
    Table 35. Global Transdermal Patch Sales Share by Type (2025-2030)
    Table 36. Global Transdermal Patch Revenue by Type (2019-2024) & (US$ Million)
    Table 37. Global Transdermal Patch Revenue by Type (2025-2030) & (US$ Million)
    Table 38. Global Transdermal Patch Revenue Share by Type (2019-2024)
    Table 39. Global Transdermal Patch Revenue Share by Type (2025-2030)
    Table 40. Transdermal Patch Price by Type (2019-2024) & (USD/Pc)
    Table 41. Global Transdermal Patch Price Forecast by Type (2025-2030) & (USD/Pc)
    Table 42. Global Transdermal Patch Sales by Application (2019-2024) & (M Pcs)
    Table 43. Global Transdermal Patch Sales by Application (2025-2030) & (M Pcs)
    Table 44. Global Transdermal Patch Sales Share by Application (2019-2024)
    Table 45. Global Transdermal Patch Sales Share by Application (2025-2030)
    Table 46. Global Transdermal Patch Revenue by Application (2019-2024) & (US$ Million)
    Table 47. Global Transdermal Patch Revenue by Application (2025-2030) & (US$ Million)
    Table 48. Global Transdermal Patch Revenue Share by Application (2019-2024)
    Table 49. Global Transdermal Patch Revenue Share by Application (2025-2030)
    Table 50. Transdermal Patch Price by Application (2019-2024) & (USD/Pc)
    Table 51. Global Transdermal Patch Price Forecast by Application (2025-2030) & (USD/Pc)
    Table 52. US & Canada Transdermal Patch Sales by Type (2019-2024) & (M Pcs)
    Table 53. US & Canada Transdermal Patch Sales by Type (2025-2030) & (M Pcs)
    Table 54. US & Canada Transdermal Patch Revenue by Type (2019-2024) & (US$ Million)
    Table 55. US & Canada Transdermal Patch Revenue by Type (2025-2030) & (US$ Million)
    Table 56. US & Canada Transdermal Patch Sales by Application (2019-2024) & (M Pcs)
    Table 57. US & Canada Transdermal Patch Sales by Application (2025-2030) & (M Pcs)
    Table 58. US & Canada Transdermal Patch Revenue by Application (2019-2024) & (US$ Million)
    Table 59. US & Canada Transdermal Patch Revenue by Application (2025-2030) & (US$ Million)
    Table 60. US & Canada Transdermal Patch Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 61. US & Canada Transdermal Patch Revenue by Country (2019-2024) & (US$ Million)
    Table 62. US & Canada Transdermal Patch Revenue by Country (2025-2030) & (US$ Million)
    Table 63. US & Canada Transdermal Patch Sales by Country (2019-2024) & (M Pcs)
    Table 64. US & Canada Transdermal Patch Sales by Country (2025-2030) & (M Pcs)
    Table 65. Europe Transdermal Patch Sales by Type (2019-2024) & (M Pcs)
    Table 66. Europe Transdermal Patch Sales by Type (2025-2030) & (M Pcs)
    Table 67. Europe Transdermal Patch Revenue by Type (2019-2024) & (US$ Million)
    Table 68. Europe Transdermal Patch Revenue by Type (2025-2030) & (US$ Million)
    Table 69. Europe Transdermal Patch Sales by Application (2019-2024) & (M Pcs)
    Table 70. Europe Transdermal Patch Sales by Application (2025-2030) & (M Pcs)
    Table 71. Europe Transdermal Patch Revenue by Application (2019-2024) & (US$ Million)
    Table 72. Europe Transdermal Patch Revenue by Application (2025-2030) & (US$ Million)
    Table 73. Europe Transdermal Patch Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 74. Europe Transdermal Patch Revenue by Country (2019-2024) & (US$ Million)
    Table 75. Europe Transdermal Patch Revenue by Country (2025-2030) & (US$ Million)
    Table 76. Europe Transdermal Patch Sales by Country (2019-2024) & (M Pcs)
    Table 77. Europe Transdermal Patch Sales by Country (2025-2030) & (M Pcs)
    Table 78. China Transdermal Patch Sales by Type (2019-2024) & (M Pcs)
    Table 79. China Transdermal Patch Sales by Type (2025-2030) & (M Pcs)
    Table 80. China Transdermal Patch Revenue by Type (2019-2024) & (US$ Million)
    Table 81. China Transdermal Patch Revenue by Type (2025-2030) & (US$ Million)
    Table 82. China Transdermal Patch Sales by Application (2019-2024) & (M Pcs)
    Table 83. China Transdermal Patch Sales by Application (2025-2030) & (M Pcs)
    Table 84. China Transdermal Patch Revenue by Application (2019-2024) & (US$ Million)
    Table 85. China Transdermal Patch Revenue by Application (2025-2030) & (US$ Million)
    Table 86. Asia Transdermal Patch Sales by Type (2019-2024) & (M Pcs)
    Table 87. Asia Transdermal Patch Sales by Type (2025-2030) & (M Pcs)
    Table 88. Asia Transdermal Patch Revenue by Type (2019-2024) & (US$ Million)
    Table 89. Asia Transdermal Patch Revenue by Type (2025-2030) & (US$ Million)
    Table 90. Asia Transdermal Patch Sales by Application (2019-2024) & (M Pcs)
    Table 91. Asia Transdermal Patch Sales by Application (2025-2030) & (M Pcs)
    Table 92. Asia Transdermal Patch Revenue by Application (2019-2024) & (US$ Million)
    Table 93. Asia Transdermal Patch Revenue by Application (2025-2030) & (US$ Million)
    Table 94. Asia Transdermal Patch Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 95. Asia Transdermal Patch Revenue by Region (2019-2024) & (US$ Million)
    Table 96. Asia Transdermal Patch Revenue by Region (2025-2030) & (US$ Million)
    Table 97. Asia Transdermal Patch Sales by Region (2019-2024) & (M Pcs)
    Table 98. Asia Transdermal Patch Sales by Region (2025-2030) & (M Pcs)
    Table 99. Middle East, Africa and Latin America Transdermal Patch Sales by Type (2019-2024) & (M Pcs)
    Table 100. Middle East, Africa and Latin America Transdermal Patch Sales by Type (2025-2030) & (M Pcs)
    Table 101. Middle East, Africa and Latin America Transdermal Patch Revenue by Type (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Transdermal Patch Revenue by Type (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Transdermal Patch Sales by Application (2019-2024) & (M Pcs)
    Table 104. Middle East, Africa and Latin America Transdermal Patch Sales by Application (2025-2030) & (M Pcs)
    Table 105. Middle East, Africa and Latin America Transdermal Patch Revenue by Application (2019-2024) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Transdermal Patch Revenue by Application (2025-2030) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Transdermal Patch Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 108. Middle East, Africa and Latin America Transdermal Patch Revenue by Country (2019-2024) & (US$ Million)
    Table 109. Middle East, Africa and Latin America Transdermal Patch Revenue by Country (2025-2030) & (US$ Million)
    Table 110. Middle East, Africa and Latin America Transdermal Patch Sales by Country (2019-2024) & (M Pcs)
    Table 111. Middle East, Africa and Latin America Transdermal Patch Sales by Country (2025-2030) & (M Pcs)
    Table 112. Hisamitsu Pharmaceutical Company Information
    Table 113. Hisamitsu Pharmaceutical Description and Major Businesses
    Table 114. Hisamitsu Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2019-2024)
    Table 115. Hisamitsu Pharmaceutical Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Hisamitsu Pharmaceutical Recent Developments
    Table 117. Johnson & Johnson Company Information
    Table 118. Johnson & Johnson Description and Major Businesses
    Table 119. Johnson & Johnson Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2019-2024)
    Table 120. Johnson & Johnson Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Johnson & Johnson Recent Developments
    Table 122. Novartis Company Information
    Table 123. Novartis Description and Major Businesses
    Table 124. Novartis Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2019-2024)
    Table 125. Novartis Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Novartis Recent Developments
    Table 127. UCB Pharma Company Information
    Table 128. UCB Pharma Description and Major Businesses
    Table 129. UCB Pharma Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2019-2024)
    Table 130. UCB Pharma Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. UCB Pharma Recent Developments
    Table 132. Mylan Company Information
    Table 133. Mylan Description and Major Businesses
    Table 134. Mylan Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2019-2024)
    Table 135. Mylan Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Mylan Recent Developments
    Table 137. Teva Pharmaceutical Company Information
    Table 138. Teva Pharmaceutical Description and Major Businesses
    Table 139. Teva Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2019-2024)
    Table 140. Teva Pharmaceutical Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Teva Pharmaceutical Recent Developments
    Table 142. Nitto Denko Company Information
    Table 143. Nitto Denko Description and Major Businesses
    Table 144. Nitto Denko Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2019-2024)
    Table 145. Nitto Denko Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Nitto Denko Recent Developments
    Table 147. Grünenthal Company Information
    Table 148. Grünenthal Description and Major Businesses
    Table 149. Grünenthal Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2019-2024)
    Table 150. Grünenthal Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Grünenthal Recent Developments
    Table 152. IBSA Group Company Information
    Table 153. IBSA Group Description and Major Businesses
    Table 154. IBSA Group Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2019-2024)
    Table 155. IBSA Group Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. IBSA Group Recent Developments
    Table 157. GSK Company Information
    Table 158. GSK Description and Major Businesses
    Table 159. GSK Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2019-2024)
    Table 160. GSK Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. GSK Recent Developments
    Table 162. Luye Pharma Group Company Information
    Table 163. Luye Pharma Group Description and Major Businesses
    Table 164. Luye Pharma Group Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2019-2024)
    Table 165. Luye Pharma Group Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Luye Pharma Group Recent Developments
    Table 167. Pfizer Company Information
    Table 168. Pfizer Description and Major Businesses
    Table 169. Pfizer Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2019-2024)
    Table 170. Pfizer Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 171. Pfizer Recent Developments
    Table 172. Chattem Company Information
    Table 173. Chattem Description and Major Businesses
    Table 174. Chattem Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2019-2024)
    Table 175. Chattem Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 176. Chattem Recent Developments
    Table 177. Dr Reddy’s Laboratories Company Information
    Table 178. Dr Reddy’s Laboratories Description and Major Businesses
    Table 179. Dr Reddy’s Laboratories Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2019-2024)
    Table 180. Dr Reddy’s Laboratories Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 181. Dr Reddy’s Laboratories Recent Developments
    Table 182. Bayer Company Information
    Table 183. Bayer Description and Major Businesses
    Table 184. Bayer Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2019-2024)
    Table 185. Bayer Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 186. Bayer Recent Developments
    Table 187. Mundipharma Company Information
    Table 188. Mundipharma Description and Major Businesses
    Table 189. Mundipharma Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2019-2024)
    Table 190. Mundipharma Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 191. Mundipharma Recent Developments
    Table 192. Endo International Company Information
    Table 193. Endo International Description and Major Businesses
    Table 194. Endo International Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2019-2024)
    Table 195. Endo International Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 196. Endo International Recent Developments
    Table 197. Beijing Tide Pharmaceutical Company Information
    Table 198. Beijing Tide Pharmaceutical Description and Major Businesses
    Table 199. Beijing Tide Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2019-2024)
    Table 200. Beijing Tide Pharmaceutical Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
    Table 201. Beijing Tide Pharmaceutical Recent Developments
    Table 202. Key Raw Materials Lists
    Table 203. Raw Materials Key Suppliers Lists
    Table 204. Transdermal Patch Distributors List
    Table 205. Transdermal Patch Customers List
    Table 206. Transdermal Patch Market Trends
    Table 207. Transdermal Patch Market Drivers
    Table 208. Transdermal Patch Market Challenges
    Table 209. Transdermal Patch Market Restraints
    Table 210. Research Programs/Design for This Report
    Table 211. Key Data Information from Secondary Sources
    Table 212. Key Data Information from Primary Sources
List of Figures
    Figure 1. Transdermal Patch Product Picture
    Figure 2. Global Transdermal Patch Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Transdermal Patch Market Share by Type in 2023 & 2030
    Figure 4. Methyl Salicylate-based Patch Product Picture
    Figure 5. Rivastigmine Transdermal Patch Product Picture
    Figure 6. Fentanyl Transdermal Patch Product Picture
    Figure 7. Lidocaine Patch Product Picture
    Figure 8. Diclofenac Patch Product Picture
    Figure 9. Nicotine Transdermal Patch Product Picture
    Figure 10. Others Product Picture
    Figure 11. Global Transdermal Patch Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 12. Global Transdermal Patch Market Share by Application in 2023 & 2030
    Figure 13. Rx Channel
    Figure 14. OTC Channel
    Figure 15. Transdermal Patch Report Years Considered
    Figure 16. Global Transdermal Patch Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Transdermal Patch Revenue 2019-2030 (US$ Million)
    Figure 18. Global Transdermal Patch Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 19. Global Transdermal Patch Revenue Market Share by Region (2019-2030)
    Figure 20. Global Transdermal Patch Sales 2019-2030 ((M Pcs)
    Figure 21. Global Transdermal Patch Sales Market Share by Region (2019-2030)
    Figure 22. US & Canada Transdermal Patch Sales YoY (2019-2030) & (M Pcs)
    Figure 23. US & Canada Transdermal Patch Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Transdermal Patch Sales YoY (2019-2030) & (M Pcs)
    Figure 25. Europe Transdermal Patch Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. China Transdermal Patch Sales YoY (2019-2030) & (M Pcs)
    Figure 27. China Transdermal Patch Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. Asia (excluding China) Transdermal Patch Sales YoY (2019-2030) & (M Pcs)
    Figure 29. Asia (excluding China) Transdermal Patch Revenue YoY (2019-2030) & (US$ Million)
    Figure 30. Middle East, Africa and Latin America Transdermal Patch Sales YoY (2019-2030) & (M Pcs)
    Figure 31. Middle East, Africa and Latin America Transdermal Patch Revenue YoY (2019-2030) & (US$ Million)
    Figure 32. The Transdermal Patch Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 33. The Top 5 and 10 Largest Manufacturers of Transdermal Patch in the World: Market Share by Transdermal Patch Revenue in 2023
    Figure 34. Global Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 35. Global Transdermal Patch Sales Market Share by Type (2019-2030)
    Figure 36. Global Transdermal Patch Revenue Market Share by Type (2019-2030)
    Figure 37. Global Transdermal Patch Sales Market Share by Application (2019-2030)
    Figure 38. Global Transdermal Patch Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada Transdermal Patch Sales Market Share by Type (2019-2030)
    Figure 40. US & Canada Transdermal Patch Revenue Market Share by Type (2019-2030)
    Figure 41. US & Canada Transdermal Patch Sales Market Share by Application (2019-2030)
    Figure 42. US & Canada Transdermal Patch Revenue Market Share by Application (2019-2030)
    Figure 43. US & Canada Transdermal Patch Revenue Share by Country (2019-2030)
    Figure 44. US & Canada Transdermal Patch Sales Share by Country (2019-2030)
    Figure 45. U.S. Transdermal Patch Revenue (2019-2030) & (US$ Million)
    Figure 46. Canada Transdermal Patch Revenue (2019-2030) & (US$ Million)
    Figure 47. Europe Transdermal Patch Sales Market Share by Type (2019-2030)
    Figure 48. Europe Transdermal Patch Revenue Market Share by Type (2019-2030)
    Figure 49. Europe Transdermal Patch Sales Market Share by Application (2019-2030)
    Figure 50. Europe Transdermal Patch Revenue Market Share by Application (2019-2030)
    Figure 51. Europe Transdermal Patch Revenue Share by Country (2019-2030)
    Figure 52. Europe Transdermal Patch Sales Share by Country (2019-2030)
    Figure 53. Germany Transdermal Patch Revenue (2019-2030) & (US$ Million)
    Figure 54. France Transdermal Patch Revenue (2019-2030) & (US$ Million)
    Figure 55. U.K. Transdermal Patch Revenue (2019-2030) & (US$ Million)
    Figure 56. Italy Transdermal Patch Revenue (2019-2030) & (US$ Million)
    Figure 57. Russia Transdermal Patch Revenue (2019-2030) & (US$ Million)
    Figure 58. China Transdermal Patch Sales Market Share by Type (2019-2030)
    Figure 59. China Transdermal Patch Revenue Market Share by Type (2019-2030)
    Figure 60. China Transdermal Patch Sales Market Share by Application (2019-2030)
    Figure 61. China Transdermal Patch Revenue Market Share by Application (2019-2030)
    Figure 62. Asia Transdermal Patch Sales Market Share by Type (2019-2030)
    Figure 63. Asia Transdermal Patch Revenue Market Share by Type (2019-2030)
    Figure 64. Asia Transdermal Patch Sales Market Share by Application (2019-2030)
    Figure 65. Asia Transdermal Patch Revenue Market Share by Application (2019-2030)
    Figure 66. Asia Transdermal Patch Revenue Share by Region (2019-2030)
    Figure 67. Asia Transdermal Patch Sales Share by Region (2019-2030)
    Figure 68. Japan Transdermal Patch Revenue (2019-2030) & (US$ Million)
    Figure 69. South Korea Transdermal Patch Revenue (2019-2030) & (US$ Million)
    Figure 70. China Taiwan Transdermal Patch Revenue (2019-2030) & (US$ Million)
    Figure 71. Southeast Asia Transdermal Patch Revenue (2019-2030) & (US$ Million)
    Figure 72. India Transdermal Patch Revenue (2019-2030) & (US$ Million)
    Figure 73. Middle East, Africa and Latin America Transdermal Patch Sales Market Share by Type (2019-2030)
    Figure 74. Middle East, Africa and Latin America Transdermal Patch Revenue Market Share by Type (2019-2030)
    Figure 75. Middle East, Africa and Latin America Transdermal Patch Sales Market Share by Application (2019-2030)
    Figure 76. Middle East, Africa and Latin America Transdermal Patch Revenue Market Share by Application (2019-2030)
    Figure 77. Middle East, Africa and Latin America Transdermal Patch Revenue Share by Country (2019-2030)
    Figure 78. Middle East, Africa and Latin America Transdermal Patch Sales Share by Country (2019-2030)
    Figure 79. Brazil Transdermal Patch Revenue (2019-2030) & (US$ Million)
    Figure 80. Mexico Transdermal Patch Revenue (2019-2030) & (US$ Million)
    Figure 81. Turkey Transdermal Patch Revenue (2019-2030) & (US$ Million)
    Figure 82. Israel Transdermal Patch Revenue (2019-2030) & (US$ Million)
    Figure 83. GCC Countries Transdermal Patch Revenue (2019-2030) & (US$ Million)
    Figure 84. Transdermal Patch Value Chain
    Figure 85. Transdermal Patch Production Process
    Figure 86. Channels of Distribution
    Figure 87. Distributors Profiles
    Figure 88. Bottom-up and Top-down Approaches for This Report
    Figure 89. Data Triangulation
    Figure 90. Key Executives Interviewed